News

Cough Monitoring App for COPD Added to NuvoAir Home Platform

NuvoAir has released a new mobile app for home use, called NuvoAir Cough, that can record and analyze coughing sounds made by patients with lung conditions, such as chronic obstructive pulmonary disease (COPD). The app is included in the NuvoAir Home platform, the company’s digital respiratory support system. Coughing…

Smiths Medical Launches Vibratory PEP Device for Lung Disorders

Smiths Medical has launched a medical device designed to help people with chronic obstructive pulmonary disease (COPD) and other respiratory diseases to clear secretions from their lungs and breathe better. “The introduction of the acapella choice blue therapy system enhances the quality of life for those living with…

Nebulized Ensifentrine Shows Promise as Add-on Therapy

Verona Pharma has announced positive efficacy and safety results about using nebulized ensifentrine as an add-on therapy to tiotropium (Spiriva Respimat) for treating symptomatic chronic obstructive pulmonary disease (COPD). Results from the Phase 2b clinical trial (NCT03937479) show that ensifentrine treatment, combined with maintenance tiotropium, results in…

Certain Mitochondrial Protein May Help Protect Airways in COPD

Scientists have found that a certain protein helps cells in the airways to clear away mucus, such as the mucus that builds up in chronic obstructive pulmonary disease (COPD). This discovery, they noted, suggests that boosting the activity of this protein, called adenine nucleotide translocase (ANT), could become a…

Study Identifies Patient Risk Factors for In-hospital Death

Certain risk factors may accurately predict in-hospital mortality, or death, in people with acute exacerbations of chronic obstructive pulmonary disease (COPD), a study revealed. These factors include the need for invasive mechanical ventilation (IMV), having chronic heart failure, and having a low number of immune white blood cells,…

Respinova Wins FDA OK for Airway Opening System Pulsehaler

Respinova’s new airway device, called Pulsehaler, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). That means it can be marketed as a safe and effective medical device to ease breathing in people with airway restrictions, such as chronic obstructive pulmonary disease (COPD). “We…

FDA Approval Sought for New Generic Version of Advair Diskus

Lannett is seeking the approval of a generic form of Advair Diskus (fluticasone-salmeterol powder) in the U.S. Such an approval would be expected to provide a less-expensive alternative to the inhalation treatment that generated about $3 billion in total U.S. sales for the 12 months ending in February 2021,…